Lipella Pharmaceuticals Inc (LIPO)
NASDAQ
Quarter End | Mar 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |||||
Total Assets | 1.52M | 4.62M | 3.49M | 2.84M | 3.58M | 3.14M | 2.18M | 2.16M |
Total Current Assets | 1.33M | 4.48M | 3.37M | 2.67M | 3.43M | 3.01M | 2.08M | 2.08M |
Cash and Equivalents | 414k | 4.02M | 3.11M | 2.41M | 3.29M | 2.11M | 1.19M | 1.35M |
Total Non-Current Assets | 187k | 137k | 123k | 183k | 161k | 138k | 114k | 90k |
Total Liabilities | 596k | 799k | 364k | 619k | 433k | 576k | 480k | 701k |
Total Current Liabilities | 346k | 718k | 299k | 548k | 386k | 552k | 480k | 701k |
Total Non-Current Liabilities | 300k | 81k | 65k | 71k | 47k | 24k | 0 | 0 |
Common Equity | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 0 |
Retained Earnings | -3.85M | -6.77M | -8.31M | -9.64M | -10.32M | -11.52M | -12.45M | -13.9M |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 955k | 2.01M | 5.95M | 3.58M |
Total Current Assets | 699k | 1.81M | 5.8M | 3.43M |
Cash and Equivalents | 607k | 1.41M | 5.12M | 3.29M |
Total Non-Current Assets | 463k | 1.42M | 4.68M | 3.14M |
Total Liabilities | 492k | 589k | 1.27M | 433k |
Total Current Liabilities | 208k | 341k | 1.18M | 386k |
Total Non-Current Liabilities | 334k | 298k | 96k | 47k |
Total Equity | 463k | 1.42M | 4.68M | 3.14M |
Common Equity | 1,000 | 1,000 | 1,000 | 1,000 |
Retained Earnings | -1.24M | -3.11M | -5.71M | -10.32M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.